- Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine
Yanbin Pang et al, 2019, Oncology Letters CrossRef - Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia
Yaqiong Tang et al, 2018, Clinical and Applied Thrombosis/Hemostasis CrossRef - Absence of early platelet increment in healthy mice during decitabine treatment
Juliane Baumann et al, 2022, Scientific Reports CrossRef - Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia
Wenxia Zhang et al, 2019, Blood Cells, Molecules, and Diseases CrossRef - Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome
Giulia Falconi et al, 2019, Leukemia Research CrossRef - Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission
Wen Yao et al, 2020, Journal of Clinical Pharmacy and Therapeutics CrossRef - Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Anurag Singh et al, 2021, Journal of Clinical Medicine CrossRef - Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine
Annette M. May et al, 2020, British Journal of Haematology CrossRef - Platelet Doubling After First Decitabine Cycle Predicts Response and Survival of Myelodysplastic Syndrome Patients
Ping-fan Lu et al, 2022, Current Medical Science CrossRef